Copyright: ©Author(s) 2026.
World J Psychiatry. Sep 19, 2026; 16(9): 118371
Published online Sep 19, 2026. doi: 10.5498/wjp.118371
Published online Sep 19, 2026. doi: 10.5498/wjp.118371
Table 1 Comparison of baseline characteristics among three groups, n (%)/mean ± SD
| Variable | Combination group | rTMS group | Control group | F/χ2 | P value |
| Gender (male/female) | 22/64 | 25/67 | 18/60 | 0.486 | 0.784 |
| Age (years) | 15.4 ± 1.7 | 15.2 ± 1.8 | 15.6 ± 1.6 | 1.125 | 0.326 |
| Illness duration (months) | 19.2 ± 9.6 | 18.5 ± 10.2 | 20.1 ± 9.8 | 0.625 | 0.536 |
| NSSI onset age (years) | 13.1 ± 1.4 | 13.3 ± 1.5 | 13.0 ± 1.6 | 0.862 | 0.424 |
| Self-injury frequency (times/month) | 8.5 ± 4.2 | 8.2 ± 4.5 | 8.8 ± 4.0 | 0.456 | 0.635 |
| Primary self-injury method | 0.562 | 0.755 | |||
| Cutting | 62 (72.1) | 68 (73.9) | 55 (70.5) | ||
| Other | 24 (27.9) | 24 (26.1) | 23 (29.5) | ||
| Comorbid depression | 52 (60.5) | 54 (58.7) | 45 (57.7) | 0.142 | 0.932 |
| Comorbid anxiety disorder | 35 (40.7) | 38 (41.3) | 30 (38.5) | 0.152 | 0.927 |
| Childhood trauma history | 48 (55.8) | 50 (54.3) | 42 (53.8) | 0.068 | 0.967 |
| Previous psychotherapy history | 28 (32.6) | 30 (32.6) | 24 (30.8) | 0.076 | 0.963 |
| SHI score (points) | 29.5 ± 7.2 | 28.8 ± 6.8 | 29.2 ± 7.0 | 0.225 | 0.799 |
| BDI-II score (points) | 27.2 ± 8.5 | 26.5 ± 8.2 | 27.0 ± 8.8 | 0.168 | 0.845 |
| BAI score (points) | 25.6 ± 7.8 | 24.8 ± 7.5 | 25.2 ± 8.0 | 0.245 | 0.783 |
| BIS-11 score (points) | 73.5 ± 11.2 | 72.8 ± 10.8 | 74.2 ± 11.5 | 0.358 | 0.699 |
| DERS score (points) | 110.5 ± 19.2 | 108.6 ± 18.5 | 111.2 ± 20.1 | 0.425 | 0.654 |
| CTQ score (points) | 48.6 ± 12.5 | 47.8 ± 11.8 | 49.2 ± 12.2 | 0.298 | 0.743 |
Table 2 Comparison of scale scores before and after treatment among three groups (mean ± SD, points)
| Measure | Time | Combination group | rTMS group | Control group | F value | P value |
| SHI | Pre-treatment | 29.5 ± 7.2 | 28.8 ± 6.8 | 29.2 ± 7.0 | 0.225 | 0.799 |
| Post-treatment | 10.8 ± 4.8a | 15.2 ± 5.5a | 19.6 ± 6.2a | 52.36 | < 0.001 | |
| Improvement | 18.7 ± 5.2 | 13.6 ± 4.8 | 9.6 ± 4.5 | 68.52 | < 0.001 | |
| BDI-II | Pre-treatment | 27.2 ± 8.5 | 26.5 ± 8.2 | 27.0 ± 8.8 | 0.168 | 0.845 |
| Post-treatment | 12.5 ± 5.6a | 16.8 ± 6.2a | 20.5 ± 7.0a | 35.62 | < 0.001 | |
| Improvement | 14.7 ± 4.8 | 9.7 ± 4.2 | 6.5 ± 3.8 | 72.86 | < 0.001 | |
| BAI | Pre-treatment | 25.6 ± 7.8 | 24.8 ± 7.5 | 25.2 ± 8.0 | 0.245 | 0.783 |
| Post-treatment | 11.2 ± 4.8a | 15.5 ± 5.6a | 18.8 ± 6.2a | 38.56 | < 0.001 | |
| Improvement | 14.4 ± 4.5 | 9.3 ± 4.0 | 6.4 ± 3.6 | 78.25 | < 0.001 | |
| BIS-11 | Pre-treatment | 73.5 ± 11.2 | 72.8 ± 10.8 | 74.2 ± 11.5 | 0.358 | 0.699 |
| Post-treatment | 54.2 ± 9.5a | 60.5 ± 10.2a | 66.8 ± 11.0a | 32.15 | < 0.001 | |
| Improvement | 19.3 ± 5.8 | 12.3 ± 5.2 | 7.4 ± 4.5 | 95.62 | < 0.001 | |
| DERS | Pre-treatment | 110.5 ± 19.2 | 108.6 ± 18.5 | 111.2 ± 20.1 | 0.425 | 0.654 |
| Post-treatment | 70.5 ± 14.2a | 82.6 ± 15.8a | 95.5 ± 17.2a | 48.26 | < 0.001 | |
| Improvement | 40.0 ± 10.5 | 26.0 ± 9.2 | 15.7 ± 8.5 | 125.8 | < 0.001 |
Table 3 Clinical efficacy comparison among three groups, n (%)
Table 4 Univariate logistic regression analysis of treatment response
| Variable | B | SE | OR (95%CI) | Wald | P value |
| Gender (male = 1) | -0.125 | 0.285 | 0.88 (0.50-1.54) | 0.192 | 0.661 |
| Age | 0.086 | 0.092 | 1.09 (0.91-1.30) | 0.875 | 0.350 |
| Illness duration | -0.042 | 0.018 | 0.96 (0.93-0.99) | 5.445 | 0.020 |
| Treatment regimen (control as reference) | 22.56 | < 0.001 | |||
| rTMS group | 0.785 | 0.312 | 2.19 (1.19-4.04) | 6.325 | 0.012 |
| Combination group | 1.652 | 0.365 | 5.22 (2.55-10.68) | 20.48 | < 0.001 |
| Comorbid depression (yes = 1) | 0.625 | 0.268 | 1.87 (1.10-3.16) | 5.445 | 0.020 |
| Comorbid anxiety disorder (yes = 1) | 0.312 | 0.265 | 1.37 (0.81-2.30) | 1.385 | 0.239 |
| Childhood trauma history (yes = 1) | -0.485 | 0.262 | 0.62 (0.37-1.03) | 3.426 | 0.064 |
| Baseline SHI score | 0.025 | 0.022 | 1.03 (0.98-1.07) | 1.292 | 0.256 |
| Baseline BDI-II score | 0.018 | 0.018 | 1.02 (0.98-1.05) | 1.000 | 0.317 |
| Baseline BIS-11 score | -0.028 | 0.014 | 0.97 (0.95-1.00) | 4.000 | 0.046 |
| Baseline DERS score | -0.022 | 0.008 | 0.98(0.96-0.99) | 7.563 | 0.006 |
Table 5 Multivariate logistic regression analysis of treatment response
| Variable | B | SE | OR (95%CI) | Wald | P value |
| Treatment regimen (control as reference) | 19.86 | < 0.001 | |||
| rTMS group | 0.695 | 0.325 | 2.00 (1.06-3.79) | 4.572 | 0.033 |
| Combination group | 1.581 | 0.388 | 4.86 (2.28-10.36) | 16.62 | < 0.001 |
| Illness duration | -0.038 | 0.019 | 0.96 (0.93-0.99) | 4.000 | 0.046 |
| Comorbid depression | 0.652 | 0.295 | 1.92 (1.08-3.42) | 4.882 | 0.027 |
| Baseline DERS score | -0.020 | 0.009 | 0.98 (0.96-0.99) | 4.938 | 0.026 |
Table 6 Multiple linear regression analysis of Self-Harm Inventory score improvement
| Variable | B | SE | β | t | P value |
| Constant | 2.856 | 2.125 | - | 1.344 | 0.180 |
| Treatment regimen (control as reference) | |||||
| rTMS group | 3.856 | 0.825 | 0.285 | 4.674 | < 0.001 |
| Combination group | 8.562 | 0.862 | 0.612 | 9.932 | < 0.001 |
| Baseline SHI score | 0.325 | 0.058 | 0.286 | 5.603 | < 0.001 |
| Baseline BIS-11 score | 0.125 | 0.038 | 0.185 | 3.289 | 0.001 |
| Childhood trauma history (yes = 1) | -2.156 | 0.752 | -0.156 | -2.867 | 0.005 |
- Citation: Liu HZ, Liu WG, Fu HQ, Lv H, Liu C, Li CX. Combined transcranial direct current and repetitive transcranial magnetic stimulation for adolescent non-suicidal self-injury. World J Psychiatry 2026; 16(9): 118371
- URL: https://www.wjgnet.com/2220-3206/full/v16/i9/118371.htm
- DOI: https://dx.doi.org/10.5498/wjp.118371